Document is current

Article History

Received: 14 February 2022

Accepted: 10 August 2022

First Online: 23 August 2022

Declarations

:

: Guru Sonpavde: Advisory Board: BMS, Genentech, EMD Serono, Merck, Sanofi, Seattle Genetics/Astellas, Astrazeneca, Exelixis, Janssen, Bicycle Therapeutics, Pfizer, Immunomedics/Gilead, Scholar Rock, G1 Therapeutics, Eli Lilly/Loxo Oncology, Infinity Pharmaceuticals; Research Support to Institution: Sanofi, Astrazeneca, Immunomedics/Gilead, QED, Predicine, BMS; Steering committee of studies: BMS, Bavarian Nordic, Seattle Genetics, QED, G1 Therapeutics (all unpaid), and Astrazeneca, EMD Serono, Debiopharm (paid); Data safety monitoring committee: Mereo; Travel costs: BMS, Astrazeneca; Writing/Editor fees: Uptodate, Editor of Elsevier Practice Update Bladder Cancer Center of Excellence; Speaking fees: Physicians Education Resource (PER), Onclive, Research to Practice, Medscape, Cancer Network, Masters Lecture Series (MLS)Benjamin Louis Maughan: Consulting or Advisory Role: Janssen Oncology, Exelixis, Tempus, Bristol Myers Squibb, Astellas Medivation, Bayer, AVEO, Clovis Oncology, Merck, Peloton Therapeutics; Research Funding: Clovis Oncology, Bristol Myers Squibb, Bavarian Nordic, Exelixis; Travel, Accommodations, Expenses: Exelixis Bradley Alexander McGregor: Consulting or Advisory Role: Bayer, Seattle Genetics/Astellas, Exelixis, AstraZeneca, Astellas Pharma, Genentech/Roche, Nextar, Janssen Oncology, Pfizer, EMD Serono, Eisai, Dendreon, Bristol Myers Squibb; Research Funding: Bristol Myers Squibb, Exelixis, Calithera Biosciences, Seattle Genetics/Astellas Xiao X. Wei: : Advisory Board: Novartis. Research support to institution: BMS.Kerry L. Kilbridge: None Richard J. Lee: Consulting or Advisory Role - Bayer; Exelixis; Janssen Oncology; Noxopharm; Tolero Pharmaceuticals; Research Funding - Janssen Evan Y. Yu: Consulting/Advisory: Abbview, Advanced Accelerator Applications, Bayer, Clovis, Exelixis, Janssen, Merck, Sanofi, Seagen; Research Support to Institution: Bayer, Blue Earth, Daiichi-Sankyo, Dendreon, Lantheus, Merck, Seagen, Taiho Michael Thomas Schweizer: paid consultant to AstraZeneca, PharmaIn, Janssen and Resverlogix; research funding to his institution from Zenith Epigenetics, Bristol Myers Squibb, Merck, Immunomedics, Janssen, AstraZeneca, Pfizer, Madison Vaccines, Hoffman-La Roche, Tmunity and SignalOne Bio, Inc.Robert B. Montgomery: None Heather H. Cheng: Consulting or Advisory Role: AstraZeneca; Research Funding: Sanofi, Janssen, Clovis Oncology, Color Genomics Foundation, Fred Hutchinson Cancer Research Center Andrew Caleb Hsieh: In last 3 years - Sponsored Research: eFFECTOR, Inc Rohit Jain: Consulting or Advisory Role - Astellas Pharma; Bayer; Eisai; EMD Serono; Infinity Pharmaceuticals; Merck; Myovant Sciences; Pfizer; Pfizer/Astellas; Propella Therapeutics; Tavanta Therapeutics; very; Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis (Inst); Seattle Genetics (Inst)Petros Grivas: (in the last 3 years): Dr. Grivas has received consulting fees from AstraZeneca, Astellas Pharma, Boston Gene, Bristol Myers Squibb,, Dyania Health, EMD Serono, Exelixis, Fresenius Kabi, Genentech/Roche, Genzyme, Gilead Sciences, GlaxoSmithKline, Guardant Health, Infinity Pharmaceuticals, Janssen, Lucence Health, Merck & Co., Mirati Therapeutics, Pfizer, QED Therapeutics, Regeneron Pharmaceuticals, Seattle Genetics, Silverback Therapeutics, 4D Pharma PLC, UroGen. His institution has received grants from Bavarian Nordic, Bristol Myers Squibb, Clovis Oncology, Debiopharm, EMD Serono, G1 Therapeutics, Gilead Sciences, GlaxoSmithKline, Merck & Co., Mirati Therapeutics, Pfizer, QED Therapeutics.Jaspreet S. Grewal: Employment - EMD Serono; Consulting or Advisory Role – Tempus; Research Funding - Bristol-Myers Squibb (Inst); Galera Therapeutics (Inst); Kartos Therapeutics (Inst); Merck (Inst); Regeneron (Inst)Cesar Pico-Navarro, Zarina Gafoor, Teresa Perschy: Employees of Bavarian-Nordic.

Free to read: This content has been made available to all.